OverviewSuggest Edit

Regenicin, Inc. is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin has assembled a world class management team with a proven track record for developing and bringing innovative medical devices and biotechnology products to market. Regenicin is working to bring the product candidate, Regenicin cultured skin substitute, to market. Regenicin cultured skin substitute is an exciting breakthrough technology that uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of chronic burns and wounds. 

TypePublic
Founded2010
HQLittle Falls, US
Websiteregenicin.com

Locations

Regenicin is headquartered in
Little Falls, United States

Location Map

Latest Updates

Employees (est.) (Sept 2019)3
Share Price (Sept 2020)$0 (-26%)
Cybersecurity ratingBMore

Key People/Management at Regenicin

Randall McCoy

Randall McCoy

Chairman and Chief Executive Officer
John Weber

John Weber

Interim CFO, Director
Show more

Regenicin Office Locations

Regenicin has an office in Little Falls
Little Falls, US (HQ)
10 High Ct
Show all (1)

Regenicin Financials and Metrics

Regenicin Revenue

USD

Net income (Q3, 2020)

(189.5k)

EBIT (Q3, 2020)

(162.1k)

Market capitalization (22-Sept-2020)

1.1m

Closing stock price (22-Sept-2020)

0.0

Cash (30-Jun-2020)

1.4k

EV

1.6m
Regenicin's current market capitalization is $1.1 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

4.4k34.1k22.5k492.01.1m218.8k19.2k2.7k815.0

Prepaid Expenses

73.6k54.3k66.3k49.5k119.2k66.2k60.6k45.3k

Current Assets

78.0k88.4k88.8k2.9m1.5m292.6k87.8k

Total Assets

3.1m3.1m96.3k2.9m1.5m359.8k87.8k56.4k5.3k
Quarterly
USDQ3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

51.1k36.2k28.9k39.0k24.5k46.2k3.2k360.0273.7k2.1m1.4m794.8k586.1k343.4k50.4k40.1k12.0k2.1k1.3k1.8k1.6k1.7k2.3k1.5k1.4k

Accounts Receivable

450.0k

Prepaid Expenses

119.0k33.5k13.4k39.5k24.7k9.9k30.2k12.1k61.6k102.0k86.2k145.7k121.7k47.4k57.2k41.0k26.0k21.7k9.8k33.5k21.7k9.8k

Current Assets

170.1k69.7k42.3k78.5k49.2k56.1k33.4k12.4k4.1m3.7m3.1m721.4k403.6k184.5k167.9k57.1k37.9k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(3.7m)(3.1m)(4.9m)2.1m242.6k(1.1m)973.9k(559.1k)

Accounts Payable

517.6k915.7k31.1k1.1k(380.3k)318.8k33.0k35.4k70.8k

Cash From Operating Activities

(1.8m)(1.1m)(685.1k)(211.8k)(2.0m)(693.3k)(311.7k)(133.7k)(126.9k)

Cash From Investing Activities

3.6m(67.3k)67.3k
USDQ3, 2011

Financial Leverage

1.5 x
Show all financial metrics

Regenicin Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Regenicin Online and Social Media Presence

Embed Graph

Regenicin Frequently Asked Questions

  • When was Regenicin founded?

    Regenicin was founded in 2010.

  • Who are Regenicin key executives?

    Regenicin's key executives are Randall McCoy and John Weber.

  • How many employees does Regenicin have?

    Regenicin has 3 employees.

  • Who are Regenicin competitors?

    Competitors of Regenicin include Endologix, Metabion International and Pfenex.

  • Where is Regenicin headquarters?

    Regenicin headquarters is located at 10 High Ct, Little Falls.

  • Where are Regenicin offices?

    Regenicin has an office in Little Falls.

  • How many offices does Regenicin have?

    Regenicin has 1 office.